查看购物车
  • Traditional Chinese
  • English
  • Japanese
亚太器官保存解决方案市场预测（2031年）- 区域分析 - 按产品、应用、类型和最终用户
市场调查报告书
商品编码
1764874

亚太器官保存解决方案市场预测（2031年）- 区域分析 - 按产品、应用、类型和最终用户

Asia Pacific Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 138 Pages | 订单完成后即时交付

价格

2023 年亚太器官保存溶液市值为 37,978.81 万美元，预计到 2031 年将达到 81,199.78 万美元；预计 2024 年至 2031 年的复合年增长率为 10.1%。

市场参与者的策略性措施推动亚太器官保存解决方案市场

各市场参与者专注于产品发布或策略合作，以开发有助于简化慢性病治疗的先进产品。近年来，市场出现了各种发展态势，例如产品发表、併购。

2022年4月，TransMedics Group, Inc. 的OCS心臟系统获得美国食品药物管理局（FDA）上市前批准，可用于循环死亡捐赠者器官的移植。 OCS心臟系统核准的扩展临床适应症包括：体外復苏、功能监测以及循环死亡捐赠者心臟的跳动保存。

2023年8月，领先的器官移植公司Paragonix Technologies的下一代捐赠者肺部保存系统BAROguard获得FDA批准。 BAROguard系统将Paragonix先进的低温保存技术与自动化、持续和主动的气道压力控制相结合。此控制确保供体肺在从捐赠者转移到接受者的整个过程中保持最佳温度范围和临床建议的充气压力范围。这种新颖的先进技术组合进一步强化了公司持续致力于改进和重新定义移植医学领域护理标准的承诺。

2024年4月，梅约诊所与寺崎生物医学创新研究所合作，旨在改善器官移植结果。梅奥诊所的生物医学研究人员和寺崎研究所的科学家计划在两个主要研究领域展开合作：即时监测捐赠器官从采购到移植手术的健康状况，以及开发预测技术以识别具有较高排斥风险的移植接受者。这将涉及创建针对抗体介导的器官移植排斥反应的预后特征和检测方法。预计初期工程将在24至30个月内完成。

因此，产品审批、上市和策略合作的激增可能为未来器官保存解决方案市场创造相当大的成长机会。

亚太器官保存解决方案市场概览

亚太地区的器官保存解决方案市场细分为中国、日本、印度、澳洲、韩国和亚太其他地区。该地区市场的成长归因于亚太地区多个国家器官移植数量的成长、人口老化加剧、导致器官衰竭的慢性病盛行率上升以及器官保存解决方案的不断发展和改进。中国预计将成为亚太地区最大的器官保存解决方案市场。中国市场的成长归因于寻求器官移植的慢性病盛行率高。根据最近的一项名为《中国慢性病与老化》的研究，中国人口正在老化，慢性病在该国的盛行率日益上升。预计从2010年到2040年，中国60岁及以上人口的比例将从12.4%上升到28%。在中国，约80%的60岁人口死亡是由于慢性非传染性疾病（NCD）造成的。慢性阻塞性肺病 (COPD)、中风、缺血性心臟病和第 2 型糖尿病是该国最常见的疾病。中国的肝癌发生率高于世界其他国家。根据世界卫生组织的数据，中国每年约有 40 万人被诊断出罹患肝癌，约 36.8 万人死于肝癌。儘管中国人口不到全球人口的 20%，但却占所有新发肝癌病例的近一半。肝细胞癌 (HCC) 约占所有原发性肝癌的 90%。它主要发生在因慢性B型肝炎或C型肝炎而患有肝硬化或瘢痕的患者身上。糖尿病和肝癌等慢性疾病会导致器官损害。因此，中国的器官移植需求不断增加，刺激了对器官保存解决方案的需求。

亚太器官保存解决方案市场收入及预测（2031 年）（千美元）

亚太器官保存解决方案市场区隔

亚太器官保存解决方案市场按产品、应用、类型、最终用户和国家分类。

根据产品类型，亚太地区器官保存液市场可分为威斯康辛大学溶液、custodiol HTK、Perfadex、HypoThermosol 等。威斯康辛大学溶液在 2023 年占据了最大的市场份额。

依应用划分，亚太地区器官保存液市场细分为静态冷藏、低温机械灌注、常温机械灌注及其他。静态冷藏领域在2023年占据了最大的市场。

按类型划分，亚太器官保存解决方案市场分为肾臟、肝臟、肺臟、心臟和其他器官。肾臟器官在2023年占据了最大的市场。

根据最终用户，亚太地区器官保存解决方案市场细分为器官移植中心、医院和专科诊所。器官移植中心在2023年占据了最大的市场。

依国家/地区划分，亚太器官保存液市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023年，中国占据亚太器官保存液市场份额的主导地位。

XVIVO Perfusion、TransMedics、Dr. Franz Koehler Chemie GmbH、Accord Healthcare 和上海 Genext Pharmaceutical Technology 是亚太地区器官保存解决方案市场的领导公司。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：亚太器官保存解决方案市场－关键市场动态

  • 市场驱动因素
    • 器官移植需求不断成长
    • 慢性病盛行率不断上升
  • 市场限制
    • 昂贵的器官移植手术
    • 器官供应有限
  • 市场机会
    • 市场参与者的策略性倡议
  • 未来趋势
    • 向机器灌注技术转变
  • 驱动因素和限制因素的影响：

第五章：器官保存解决方案市场—亚太地区分析

  • 器官保存解决方案市场收入（2021-2031）
  • 器官保存液市场预测分析

第六章：亚太地区器官保存解决方案市场分析（按产品）

  • 威斯康辛大学解决方案
  • 库斯托迪奥尔HTK
  • 佩法德斯
  • 低温溶胶
  • 其他的

第七章：亚太地区器官保存解决方案市场分析-按应用

  • 静态冷藏
  • 低温机灌注
  • 常温机灌注
  • 其他的

第八章：亚太器官保存解决方案市场分析 - 按类型

  • 肾臟
  • 肝
  • 肺
  • 心
  • 其他的

第九章：亚太地区器官保存解决方案市场分析－按最终用户

  • 器官移植中心
  • 医院
  • 专科诊所

第十章：亚太器官保存解决方案市场—国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 11 章：器官保存解决方案市场-产业格局

  • 概述
  • 器官保存解决方案市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十二章：公司简介

  • XVIVO Perfusion
  • TransMedics
  • Dr. Franz Koehler Chemie GmbH
  • Accord Healthcare
  • Shanghai Genext Pharmaceutical Technology

第 13 章：附录

Product Code: TIPRE00025780

The Asia Pacific organ preservation solution market was valued at US$ 37,978.81 thousand in 2023 and is expected to reach US$ 81,199.78 thousand by 2031; it is estimated to register a CAGR of 10.1% from 2024 to 2031.

Strategic Initiatives by Market Players Fuels Asia Pacific Organ Preservation Solution Market

Various market players focus on product launches or strategic collaborations to develop advanced products that help ease the treatment of chronic disorders. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years.

In April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart System for using it with organs procured from donors after circulatory death. The OCS Heart System is approved with the extended clinical indication for ex vivo reanimation, functional monitoring, and beating-heart preservation of donors-after-circulatory-death (DCD) hearts.

In August 2023, Paragonix Technologies, a leading organ transplant company, received FDA clearance for its next-generation donor lung preservation system-BAROguard. The BAROguard system combines Paragonix's advanced hypothermic preservation technology with automated continuous and active airway pressure control. This control ensures the maintenance of optimal temperature range and a clinically recommended inflation pressure range for donor's lungs throughout their transfer from donors to recipients. This novel combination of advanced technologies further reinforces the company's ongoing commitment to improving and redefining the standard of care within the field of transplant medicine.

In April 2024, the Mayo Clinic and the Terasaki Institute for Biomedical Innovation collaborated to improve organ transplant outcomes. Mayo Clinic biomedical researchers and Terasaki Institute scientists plan to collaborate on two main study areas: real-time monitoring of donated organ health from procurement to transplant surgery and the development of predictive technologies to identify transplant recipients with a higher risk of rejection. This will involve creating prognostic signatures and assays for antibody-mediated rejection of organ transplants. The initial projects are expected to be completed within 24-30 months.

Thus, a surge in product approvals, launches, and strategic collaborations is likely to create considerable growth opportunities for the organ preservation solution market in the future.

Asia Pacific Organ Preservation Solution Market Overview

The organ preservation solution market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is attributed to the growing number of organ transplantations across several countries in Asia Pacific, increasing aging population, rising prevalence of chronic diseases that lead to organ failure, and increasing developments and improvements in organ preservation solutions. China is expected to be the largest market for organ preservation solutions in Asia Pacific. The market growth in the country is attributed to the high prevalence of chronic diseases seeking organ transplantation. According to a recent study, "Chronic Illness and Ageing in China," China's population is aging, and chronic illnesses are increasingly prevalent in the country. The proportion of people aged 60 years and above in China is expected to rise from 12.4% to 28% from 2010 to 2040. In China, ~80% of deaths of people aged 60 years are reported due to chronic noncommunicable diseases (NCDs). Chronic obstructive pulmonary disease (COPD), stroke, ischemic heart disease, and type 2 diabetes are among the most prevalent diseases in the country. China has a greater rate of liver cancer than other countries across the world. According to the World Health Organization, ~400,000 people are diagnosed with liver cancer, and around 368,000 people die due to the disease in China every year. Although accounting for less than 20% of the global population, China accounts for nearly half of all new liver cancer cases. Hepatocellular carcinoma (HCC) represents roughly 90 % of all occurrences of primary liver cancer. It develops mainly in those patients with cirrhosis, or scarring, due to chronic hepatitis B or C. Chronic diseases such as diabetes and liver cancer lead to organ damage. Therefore, the need for organ transplants has increased in China, bolstering the demand for organ preservation solutions.

Asia Pacific Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

Asia Pacific Organ Preservation Solution Market Segmentation

The Asia Pacific organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the Asia Pacific organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the Asia Pacific organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the Asia Pacific organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the Asia Pacific organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the Asia Pacific organ preservation solution market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific organ preservation solution market share in 2023.

XVIVO Perfusion, TransMedics, Dr. Franz Koehler Chemie GmbH, Accord Healthcare, and Shanghai Genext Pharmaceutical Technology, are among the leading companies operating in the Asia Pacific organ preservation solution market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Organ Preservation Solution Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Need for Organ Transplantation
    • 4.1.2 Increasing Prevalence of Chronic Diseases
  • 4.2 Market Restraints
    • 4.2.1 Expensive Organ Transplant Surgeries
    • 4.2.2 Limited Organ Availability
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Market Players
  • 4.4 Future Trends
    • 4.4.1 Shift Toward Machine Perfusion Technique
  • 4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - Asia Pacific Analysis

  • 5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
  • 5.2 Organ Preservation Solution Market forecast Analysis

6. Asia Pacific Organ Preservation Solution Market Analysis - by Product

  • 6.1 University of Wisconsin Solution
    • 6.1.1 Overview
    • 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.2 Custodiol HTK
    • 6.2.1 Overview
    • 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.3 Perfadex
    • 6.3.1 Overview
    • 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.4 HypoThermosol
    • 6.4.1 Overview
    • 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 6.5 Others
    • 6.5.1 Overview
    • 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. Asia Pacific Organ Preservation Solution Market Analysis - by Application

  • 7.1 Static Cold Storage
    • 7.1.1 Overview
    • 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.2 Hypothermic Machine Perfusion
    • 7.2.1 Overview
    • 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.3 Normothermic Machine Perfusion
    • 7.3.1 Overview
    • 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. Asia Pacific Organ Preservation Solution Market Analysis - by Type

  • 8.1 Kidneys
    • 8.1.1 Overview
    • 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.2 Liver
    • 8.2.1 Overview
    • 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.3 Lungs
    • 8.3.1 Overview
    • 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.4 Heart
    • 8.4.1 Overview
    • 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. Asia Pacific Organ Preservation Solution Market Analysis - by End User

  • 9.1 Organ Transplant Centers
    • 9.1.1 Overview
    • 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 9.2 Hospitals
    • 9.2.1 Overview
    • 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • 9.3 Specialty Clinics
    • 9.3.1 Overview
    • 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. Asia Pacific Organ Preservation Solution Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 10.1.1.1 Asia Pacific: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
      • 10.1.1.2 China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.2.1 China: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.2.2 China: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.2.3 China: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.2.4 China: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.3 Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.3.1 Japan: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.3.2 Japan: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.3.3 Japan: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.3.4 Japan: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.4 India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.4.1 India: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.4.2 India: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.4.3 India: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.4.4 India: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.5 Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.5.1 Australia: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.5.2 Australia: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.5.3 Australia: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.5.4 Australia: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.6 South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.6.1 South Korea: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.6.2 South Korea: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.6.3 South Korea: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.6.4 South Korea: Organ Preservation Solution Market Breakdown, by End User
      • 10.1.1.7 Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
        • 10.1.1.7.1 Rest of APAC: Organ Preservation Solution Market Breakdown, by Product
        • 10.1.1.7.2 Rest of APAC: Organ Preservation Solution Market Breakdown, by Application
        • 10.1.1.7.3 Rest of APAC: Organ Preservation Solution Market Breakdown, by Type
        • 10.1.1.7.4 Rest of APAC: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organ Preservation Solutions Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 XVIVO Perfusion
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 TransMedics
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Dr. Franz Koehler Chemie GmbH
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Accord Healthcare
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Shanghai Genext Pharmaceutical Technology
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Organ Preservation Solution Market Segmentation
  • Table 2. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Table 3. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 4. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 5. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 6. Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 7. Asia Pacific: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Country
  • Table 8. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 9. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 10. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 11. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 12. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 13. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 14. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 15. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 16. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 17. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 18. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 19. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 20. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 21. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 22. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 23. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 24. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 25. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 26. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 27. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 28. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Product
  • Table 29. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Application
  • Table 30. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by Type
  • Table 31. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand) - by End User
  • Table 32. Recent Organic Growth Strategies in Organ Preservation Solutions Market
  • Table 33. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
  • Table 34. Glossary of Terms, Organ Preservation Solution Market

List Of Figures

  • Figure 1. Asia Pacific Organ Preservation Solution Market Segmentation, by Country
  • Figure 2. Organ Preservation Solution Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Organ Preservation Solution Market Share (%) - by Product (2023 and 2031)
  • Figure 6. University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 7. Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 8. Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 9. HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 10. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 11. Organ Preservation Solution Market Share (%) - by Application (2023 and 2031)
  • Figure 12. Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 13. Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 14. Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 15. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 16. Organ Preservation Solution Market Share (%) - by Type (2023 and 2031)
  • Figure 17. Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 18. Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 19. Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 20. Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 21. Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 22. Organ Preservation Solution Market Share (%) - by End User (2023 and 2031)
  • Figure 23. Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 24. Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 25. Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 26. Asia Pacific Organ Preservation Solution Market, by Key Country - Revenue (2023) (US$ Thousand)
  • Figure 27. Asia Pacific: Organ Preservation Solution Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 28. China: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 29. Japan: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 30. India: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 31. Australia: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 32. South Korea: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 33. Rest of APAC: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
  • Figure 34. Growth Strategies in Organ Preservation Solutions Market